DENISE HIXON: Open Payments
NPI 1548455280 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,180 in 101 payments from 18 companies in 2025. Trend: 2023 $1,178 · 2024 $2,060 · 2025 $2,180
Food & beverage: $2,004Education: $176
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $397 |
| Regeneron Healthcare Solutions, Inc. | 11 | $331 |
| UCB, Inc. | 7 | $261 |
| GENZYME CORPORATION | 8 | $242 |
| Lilly USA, LLC | 10 | $214 |
| Galderma Laboratories, L.P. | 13 | $145 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $136 |
| Novartis Pharmaceuticals Corporation | 6 | $131 |
| Almirall LLC | 3 | $70 |
| ABBVIE INC. | 3 | $59 |
Products named: DUPIXENT, TREMFYA, Bimzelx, TALTZ, NEMLUVIO, Seysara, COSENTYX, RINVOQ.
Industry payments across TX — which companies pay providers there.
